Neuropeptide receptors as potential pharmacological targets for obesity

Obesity is a chronic multifactorial disease, characterized by an excessive accumulation of adipose tissue. It is usually the result of excessive food intake and/or low energy expenditure. Obesity can be triggered by lifestyle, nutritional, genetic, environmental, hormonal and psychological factors....

Full description

Saved in:
Bibliographic Details
Published in:Pharmacology & therapeutics (Oxford) 2019-04, Vol.196, p.59-78
Main Authors: Meneguetti, Beatriz T., Cardoso, Marlon H., Ribeiro, Camila F.A., Felício, Mário R., Pinto, Ingrid B., Santos, Nuno C., Carvalho, Cristiano M.E., Franco, Octávio L.
Format: Article
Language:English
Subjects:
Animals
Food intake
GPCRs
Humans
Hunger
Hypothalamus
Neuropeptides
Obesity
Obesity - drug therapy
Obesity - metabolism
Obesity - physiopathology
Peptide hormones
Receptors, Neuropeptide - physiology
Satiety Response
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Obesity is a chronic multifactorial disease, characterized by an excessive accumulation of adipose tissue. It is usually the result of excessive food intake and/or low energy expenditure. Obesity can be triggered by lifestyle, nutritional, genetic, environmental, hormonal and psychological factors. Several strategies are used to treat obesity, including dietary reeducation, with balanced food intake, increased physical exercise, in order to promote energy expenditure and to overcome the insufficiency in weight reduction by other strategies, and administration of drugs. However, these medications are associated to undesirable side effects, resulting in a high withdrawal rate. Several studies have been focused on the development of compounds that act in the hypothalamic region where the center of the regulation of hunger and satiety is located. Some of them target the activity of endogenous peptides, such as ghrelin pancreatic polypeptide, peptide YY and neuropeptide Y, as well as their receptors. This review addresses the importance of understanding the neuropeptide/peptide hormones and their receptors for the development of novel anti-obesity compounds that may aid in weight reduction as a promising alternative for the treatment of obesity.
ISSN:0163-7258
1879-016X
DOI:10.1016/j.pharmthera.2018.11.002